Sofosbuvir: Indication of added benefit for specific patients

(Institute for Quality and Efficiency in Health Care) Sofosbuvir may have advantages in genotype 2 chronic hepatitis C. The extent of added benefit is unclear, however. There were no suitable data on other virus types in the dossier.